Home › Funds › Capital International, Inc./CA/ › VRTX

Capital International, Inc./CA/ position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

Capital International, Inc./CA/ reported holding 154,495 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$80.8M, representing 0.58% of its reported portfolio and ranking #46 among its reported holdings. Capital International, Inc./CA/ has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)154.50K sh
Reported value held$80.77M
Portfolio Weight0.58%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Capital International, Inc./CA/'s VRTX position evolved

Capital International, Inc./CA/ first disclosed a stake in VRTX in Q3 2023 at 61,941 shares (US$21.5M). The position peaked in Q2 2026 at 164,407 shares, worth US$81.7M. Across 13 filings, Capital International, Inc./CA/ increased the stake 10 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 154,495 shares valued at US$80.8M — a reduction of -9,912 shares quarter over quarter.. Notable position changes include a 26% increase in Q4 2023 (shares rose 2% over the following quarter), a 26% increase in Q1 2024 (shares rose 12% over the following quarter), a 34% increase in Q2 2025 (shares fell 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 61.94K $21.54M New
Q4 2023 78.04K $31.75M Add
Q1 2024 98.53K $41.18M Add
Q2 2024 106.18K $49.77M Add
Q3 2024 110.35K $51.32M Add
Q4 2024 124.13K $49.99M Add
Q1 2025 131.22K $63.62M Add
Q2 2025 175.23K $78.01M Add
Q3 2025 191.34K $74.94M Add
Q4 2025 159.66K $72.38M Reduce
Q1 2026 161.72K $72.22M Add
Q2 2026 164.41K $81.67M Add
Q3 2026 154.50K $80.77M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 32 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$13.58B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has Capital International, Inc./CA/ held VRTX?

Capital International, Inc./CA/ has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Capital International, Inc./CA/'s current position in VRTX?

As of Q3 2026, Capital International, Inc./CA/ holds 154.50K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $80.77M, representing 0.58% of its reported portfolio and ranking #46.

Has Capital International, Inc./CA/ been buying or selling VRTX?

In the latest 13F filing (Q3 2026), Capital International, Inc./CA/ reduced its position in VRTX. The position peaked in Q2 2026 at 164.41K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.